Amiri, D.; Shah, S.J.; Briziarelli, L.; Amiri, S.; Karlsson, B.
Treatment-Resistant Depression as a Heterogeneous Clinical Syndrome: A Personalized Medicine Framework for Diagnostic Reassessment, Suicide Risk, and Mechanism-Based Treatment. J. Pers. Med. 2026, 16, 468.
https://doi.org/10.3390/jpm16090468
AMA Style
Amiri D, Shah SJ, Briziarelli L, Amiri S, Karlsson B.
Treatment-Resistant Depression as a Heterogeneous Clinical Syndrome: A Personalized Medicine Framework for Diagnostic Reassessment, Suicide Risk, and Mechanism-Based Treatment. Journal of Personalized Medicine. 2026; 16(9):468.
https://doi.org/10.3390/jpm16090468
Chicago/Turabian Style
Amiri, Davoud, Swetang J. Shah, Lamberto Briziarelli, Sara Amiri, and Barry Karlsson.
2026. "Treatment-Resistant Depression as a Heterogeneous Clinical Syndrome: A Personalized Medicine Framework for Diagnostic Reassessment, Suicide Risk, and Mechanism-Based Treatment" Journal of Personalized Medicine 16, no. 9: 468.
https://doi.org/10.3390/jpm16090468
APA Style
Amiri, D., Shah, S. J., Briziarelli, L., Amiri, S., & Karlsson, B.
(2026). Treatment-Resistant Depression as a Heterogeneous Clinical Syndrome: A Personalized Medicine Framework for Diagnostic Reassessment, Suicide Risk, and Mechanism-Based Treatment. Journal of Personalized Medicine, 16(9), 468.
https://doi.org/10.3390/jpm16090468
